JP2006517788A - １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物 - Google Patents

１５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物 Download PDF

Info

Publication number
JP2006517788A
JP2006517788A JP2005509989A JP2005509989A JP2006517788A JP 2006517788 A JP2006517788 A JP 2006517788A JP 2005509989 A JP2005509989 A JP 2005509989A JP 2005509989 A JP2005509989 A JP 2005509989A JP 2006517788 A JP2006517788 A JP 2006517788A
Authority
JP
Japan
Prior art keywords
antibody
cancer
colon
mrna
normal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005509989A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517788A5 (https=
Inventor
エリック エス． ライトキャップ，
ジェフリー エー． イクセディー，
ジョン ジェイ． ハンター，
カイル ジェイ． マクベス，
ミッチェル ティー ネスター，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of JP2006517788A publication Critical patent/JP2006517788A/ja
Publication of JP2006517788A5 publication Critical patent/JP2006517788A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2005509989A 2002-12-20 2003-12-16 １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物 Pending JP2006517788A (ja)

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US43510802P 2002-12-20 2002-12-20
US43644302P 2002-12-23 2002-12-23
US43849803P 2003-01-07 2003-01-07
US44437003P 2003-01-31 2003-01-31
US44603103P 2003-02-06 2003-02-06
US45363503P 2003-03-11 2003-03-11
US45719903P 2003-03-25 2003-03-25
US46245803P 2003-04-10 2003-04-10
US46673203P 2003-04-30 2003-04-30
US46918403P 2003-05-08 2003-05-08
US47166303P 2003-05-19 2003-05-19
US47547203P 2003-06-03 2003-06-03
US47815003P 2003-06-12 2003-06-12
US48063103P 2003-06-23 2003-06-23
US48736903P 2003-07-15 2003-07-15
US49086603P 2003-07-29 2003-07-29
US49961403P 2003-09-02 2003-09-02
US51008103P 2003-10-09 2003-10-09
US51774203P 2003-11-06 2003-11-06
PCT/US2003/040226 WO2004058153A2 (en) 2002-12-20 2003-12-16 Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.

Publications (2)

Publication Number Publication Date
JP2006517788A true JP2006517788A (ja) 2006-08-03
JP2006517788A5 JP2006517788A5 (https=) 2006-12-07

Family

ID=32686484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005509989A Pending JP2006517788A (ja) 2002-12-20 2003-12-16 １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物

Country Status (5)

Country Link
US (1) US20040235071A1 (https=)
EP (1) EP1572118A4 (https=)
JP (1) JP2006517788A (https=)
AU (1) AU2003297318A1 (https=)
WO (1) WO2004058153A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005030953A1 (ja) * 2003-09-30 2006-12-07 第一製薬株式会社 テトラヒドロ葉酸合成酵素遺伝子
JP2012517607A (ja) * 2009-02-20 2012-08-02 オンコノム，インコーポレイテッド 大腸癌の診断及び予後判定のための用具セット及び方法
JP2012525121A (ja) * 2009-04-29 2012-10-22 ガニメド ファーマシューティカルズ アーゲー 診断および治療のための腫瘍関連マーカーの同定

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080050836A1 (en) * 1998-05-01 2008-02-28 Isabelle Guyon Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia
AU1891601A (en) * 1999-12-16 2001-06-25 Chugai Research Institute For Molecular Medicine, Inc. Novel human RNA helicase, helicain
US20090226915A1 (en) * 2001-01-24 2009-09-10 Health Discovery Corporation Methods for Screening, Predicting and Monitoring Prostate Cancer
US20030153018A1 (en) * 2001-11-27 2003-08-14 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
US8008012B2 (en) 2002-01-24 2011-08-30 Health Discovery Corporation Biomarkers downregulated in prostate cancer
US20070134660A1 (en) * 2003-05-30 2007-06-14 Rosetta Inpharmatics Llc Methods for identifying modulators of kinesin activity
US20100022625A1 (en) * 2006-06-29 2010-01-28 Srivastava Satish K Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
US20070021366A1 (en) 2004-11-19 2007-01-25 Srivastava Satish K Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
US11105808B2 (en) 2004-11-12 2021-08-31 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
DE102004059781A1 (de) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
US20100151572A1 (en) * 2005-05-16 2010-06-17 Sorscher Eric J Anti-tumoral compositions methods
WO2007037473A1 (ja) * 2005-09-30 2007-04-05 Daiichi Pharmaceutical Co., Ltd. 細胞遊走阻害方法および細胞遊走阻害剤
US20070092585A1 (en) * 2005-10-14 2007-04-26 Skinner Michael K Cancer chemotherapy compositions comprising PI3K pathways modulators and triptolide
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
NZ592461A (en) 2008-10-22 2012-12-21 Oncotherapy Science Inc Rab6kifl/kif20a epitope peptide and vaccines containing the same
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Ｋｎｔｃ２胜肽及含此胜肽之疫苗
EP2806274A1 (en) * 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lung cancer diagnostic method and means
WO2021007527A1 (en) * 2019-07-11 2021-01-14 University Of Utah Research Foundation Compositions and methods for treating peroxisomal biogenesis disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002539826A (ja) * 1999-03-26 2002-11-26 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム 新規化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1108021A2 (en) * 1998-08-31 2001-06-20 Bayer Corporation Human genes differentially expressed in colorectal cancer
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
KR100876327B1 (ko) * 2001-02-21 2008-12-31 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 진단에서의, 그리고 암에서 치료 표적으로서의 ｔｔｋ
AU2002319180B2 (en) * 2001-05-23 2007-07-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Pyruvate-kinase as a novel target molecule
WO2002098891A2 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002539826A (ja) * 1999-03-26 2002-11-26 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム 新規化合物

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005030953A1 (ja) * 2003-09-30 2006-12-07 第一製薬株式会社 テトラヒドロ葉酸合成酵素遺伝子
JP4634302B2 (ja) * 2003-09-30 2011-02-16 第一三共株式会社 テトラヒドロ葉酸合成酵素遺伝子
US8168392B2 (en) 2003-09-30 2012-05-01 Daiichi Sankyo Co., Ltd. Tetrahydrofolate synthetase gene
JP2012517607A (ja) * 2009-02-20 2012-08-02 オンコノム，インコーポレイテッド 大腸癌の診断及び予後判定のための用具セット及び方法
JP2012525121A (ja) * 2009-04-29 2012-10-22 ガニメド ファーマシューティカルズ アーゲー 診断および治療のための腫瘍関連マーカーの同定

Also Published As

Publication number Publication date
AU2003297318A8 (en) 2010-02-11
EP1572118A4 (en) 2010-07-14
AU2003297318A1 (en) 2004-07-22
US20040235071A1 (en) 2004-11-25
WO2004058153A2 (en) 2004-07-15
WO2004058153A9 (en) 2010-01-21
EP1572118A2 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
JP2006517788A (ja) １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物
JP2005522999A (ja) 癌を処置するための方法および組成物
JP2007520996A (ja) ４４３９０、５４１８１、２１１、５６８７、８８４、１４０５、６３６、４４２１、５４１０、３０９０５、２０４５、１６４０５、１８５６０、２０４７、３３７５１、５２８７２、１４０６３、２０７３９、３２５４４、４３２３９、４４３７３、５１１６４、５３０１０、１６８５２、１５８７、２２０７、２２２４５、２３８７、５２９０８、６９１１２、１４９９０、１８５４７、１１５、５７９、１５９８５、１５６２５、７６０、１８６０３、２３９５、２５５４、８６７５、３２７２０、４８０９、１４３０３、１６８１６、１７８２７、３２６２０、５７７、６１９、１４２３、２１５８、８２６３、１５４０２、１６２０９、１６３８６、２１１６５、３０９１１、４１８９７、１６４３、２５４３、９６２６、１３２３１、３２４０９、８４２６０、２８８２、８２０３、３２６７８または５５０５３を用いて泌尿器科障害を処置するための方法および組成物
KR20050104045A (ko) 종양 억제자로 작용하는 ａｉｍ3의 신규 용도
US20080044833A1 (en) Diagnostic PKM2 methods and compositions
US20050037946A1 (en) Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
US20030152574A1 (en) Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2210
JP2005513422A (ja) 癌を処置するための方法および組成物
US7037668B2 (en) Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
JP2005508169A (ja) ２０７５０を使用した細胞増殖障害の診断および処置のための方法および組成物
US20030148394A1 (en) Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058, or 6351 molecules
US20030124593A1 (en) Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
JP2010117358A (ja) 癌に関与するタンパク質
US20030113777A1 (en) Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
US20030104455A1 (en) Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524
US20030113776A1 (en) Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 54394
US20030114408A1 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 86604

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061020

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100518